Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a Ready-to-Use Graphical Tool Based on Artificial Neural Network Classification: Application for the Prediction of Late Fecal Incontinence After Prostate Cancer Radiation Therapy.
Carrara M, Massari E, Cicchetti A, Giandini T, Avuzzi B, Palorini F, Stucchi C, Fellin G, Gabriele P, Vavassori V, Degli Esposti C, Cozzarini C, Pignoli E, Fiorino C, Rancati T, Valdagni R. Carrara M, et al. Among authors: degli esposti c. Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1533-1542. doi: 10.1016/j.ijrobp.2018.07.2014. Epub 2018 Aug 6. Int J Radiat Oncol Biol Phys. 2018. PMID: 30092335
Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy.
Palorini F, Rancati T, Cozzarini C, Improta I, Carillo V, Avuzzi B, Casanova Borca V, Botti A, Degli Esposti C, Franco P, Garibaldi E, Girelli G, Iotti C, Maggio A, Palombarini M, Pierelli A, Pignoli E, Vavassori V, Valdagni R, Fiorino C. Palorini F, et al. Among authors: degli esposti c. Radiother Oncol. 2016 Jan;118(1):92-8. doi: 10.1016/j.radonc.2015.11.036. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777123 Clinical Trial.
Baseline status and dose to the penile bulb predict impotence 1 year after radiotherapy for prostate cancer.
Cozzarini C, Rancati T, Badenchini F, Palorini F, Avuzzi B, Degli Esposti C, Girelli G, Improta I, Vavassori V, Valdagni R, Fiorino C. Cozzarini C, et al. Among authors: degli esposti c. Strahlenther Onkol. 2016 May;192(5):297-304. doi: 10.1007/s00066-016-0964-1. Epub 2016 Apr 14. Strahlenther Onkol. 2016. PMID: 27079673 Clinical Trial. English.
Patterns in ano-rectal dose maps and the risk of late toxicity after prostate IMRT.
Onjukka E, Fiorino C, Cicchetti A, Palorini F, Improta I, Gagliardi G, Cozzarini C, Degli Esposti C, Gabriele P, Valdagni R, Rancati T. Onjukka E, et al. Among authors: degli esposti c. Acta Oncol. 2019 Dec;58(12):1757-1764. doi: 10.1080/0284186X.2019.1635267. Epub 2019 Jul 12. Acta Oncol. 2019. PMID: 31298076
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study).
Antonelli A, Palumbo C, Noale M, Artibani W, Bassi P, Bertoni F, Bracarda S, Bruni A, Corvò R, Gacci M, Magrini SM, Montironi R, Porreca A, Tubaro A, Zagonel V, Maggi S; Pros-IT CNR study group. Antonelli A, et al. Minerva Urol Nefrol. 2020 Oct;72(5):595-604. doi: 10.23736/S0393-2249.19.03637-3. Epub 2020 Jan 7. Minerva Urol Nefrol. 2020. PMID: 31920063 Free article.
The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study.
Gacci M, Greco I, Artibani W, Bassi P, Bertoni F, Bracarda S, Briganti A, Carmignani G, Carmignani L, Conti GN, Corvò R, DE Nunzio C, Fusco F, Graziotti P, Maggi S, Magrini SM, Mirone V, Montironi R, Muto G, Noale M, Pecoraro S, Porreca A, Ricardi U, Russi E, Salonia A, Simonato A, Serni S, Tubaro A, Zagonel V, Crepaldi G; Pros-IT CNR Study Group. Gacci M, et al. Minerva Urol Nephrol. 2022 Feb;74(1):38-48. doi: 10.23736/S2724-6051.20.03925-9. Epub 2020 Nov 17. Minerva Urol Nephrol. 2022. PMID: 33200896 Free article.
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study.
Palumbo C, Bruni A, Antonelli A, Artibani W, Bassi P, Bertoni F, Borghetti P, Bracarda S, Cicchetti A, Corvò R, Gacci M, Ingrosso G, Magrini SM, Maruzzo M, Mirone V, Montironi R, Muto G, Noale M, Porreca A, Russi E, Triggiani L, Tubaro A, Valdagni R, Maggi S, Conti GN; Pros-IT CNR Study Group. Palumbo C, et al. Minerva Urol Nephrol. 2022 Feb;74(1):11-20. doi: 10.23736/S2724-6051.20.04032-1. Epub 2021 Jan 13. Minerva Urol Nephrol. 2022. PMID: 33439570 Free article.
Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patients.
Cicchetti A, Fiorino C, Ebert MA, Iacovacci J, Kennedy A, Joseph DJ, Denham JW, Vavassori V, Fellin G, Cozzarini C, Esposti CD, Gabriele P, Munoz F, Avuzzi B, Valdagni R, Rancati T. Cicchetti A, et al. Among authors: esposti cd. Radiother Oncol. 2023 Jun;183:109628. doi: 10.1016/j.radonc.2023.109628. Epub 2023 Mar 18. Radiother Oncol. 2023. PMID: 36934896
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study.
Gacci M, Artibani W, Bassi P, Bertoni F, Bracarda S, Briganti A, Carmignani G, Carmignani L, Conti G, Corvò R, De Nunzio C, Fusco F, Graziotti P, Greco I, Maggi S, Magrini SM, Mirone V, Montironi R, Morgia G, Muto G, Noale M, Pecoraro S, Porreca A, Ricardi U, Russi E, Russo G, Salonia A, Simonato A, Serni S, Tomasini D, Tubaro A, Zagonel V, Crepaldi G; MIRROR-SIU/LUNA Study Group and the Pros-IT CNR Study Group. Gacci M, et al. World J Urol. 2021 May;39(5):1445-1452. doi: 10.1007/s00345-020-03350-5. Epub 2020 Aug 1. World J Urol. 2021. PMID: 32740803
31 results